Home BancShares, Inc. Announces Fourth Quarter Earnings

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Home BancShares, Inc. Announces Fourth Quarter Earnings Release Date and Conference Call

CONWAY, Ark., Dec. 28, 2016 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NASDAQ: HOMB ), parent company of Centennial Bank, today announced it expects to release Fourth Quarter 2016 earnings before the market opens on January 19, 2017.  Following this release, management will conduct a conference call to review these earnings at 1:00 p.m. CT (2:00 ET) on Thursday, January 19, 2017.

We encourage all participants to pre-register for the conference call using the following link:  http://dpregister.com/10098283 .  Callers who pre-register will be given dial-in instructions and a unique PIN to gain immediate access to the live call.  Participants may pre-register now, or at any time prior to the call, and will immediately receive simple instructions via email.  The Home BancShares conference call will also be automatically scheduled as an event in your Outlook calendar.

Those without internet access or unable to pre-register may dial in and listen to the live call by calling 1-877-508-9586 and asking for the Home BancShares conference call.  A replay of the call will be available by calling 1-877-344-7529, Passcode: 10098283, which will be available until January 26, 2017 at 10:59 p.m. CT (11:59 ET).  Internet access to the call will be available live or in recorded version on the Company's website at www.homebancshares.com . 

Home BancShares, Inc. is a bank holding company, headquartered in Conway, Arkansas. Its wholly-owned subsidiary, Centennial Bank, provides a broad range of commercial and retail banking plus related financial services to businesses, real estate developers, investors, individuals and municipalities. Centennial Bank has branch locations in Arkansas, Florida, South Alabama and New York City. The Company’s common stock is traded through the NASDAQ Global Select Market under the symbol “HOMB.”

This release contains forward-looking statements regarding the Company's plans, expectations, goals and outlook for the future. Statements in this press release that are not historical facts should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements of this type speak only as of the date of this news release. By nature, forward-looking statements involve inherent risk and uncertainties. Various factors, including, but not limited to, economic conditions, credit quality, interest rates, loan demand, the ability to successfully integrate new acquisitions and changes in the assumptions used in making the forward-looking statements, could cause actual results to differ materially from those contemplated by the forward-looking statements. Additional information on factors that might affect Home BancShares, Inc.'s financial results is included in its Annual Report on Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission (the “SEC”) on February 26, 2016.     

FOR MORE INFORMATION CONTACT: Home BancShares, Inc. Jennifer C. Floyd Chief Accounting Officer & Investor Relations Officer (501) 339-2929

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 28

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 23

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 24

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Revolutionizes Trading: Insights from FBS Analysts

Updated Category News Views 358

AI's Impact on Trading: Key Developments and Insights In recent years, artificial intelligence (AI) has significantly influenced various industries, and trading is no exception. FBS, a prominent global broker, has conducted a deep dive into this revolutionary shift. They emphasize how AI is enhancing the efficiency, accuracy, and overall decision-making processes in...

Continue Reading
Alerus Financial Corp: Anticipated Earnings Report Insights

Updated Category News Views 131

Insights into Alerus Financial Corp’s Upcoming Earnings Alerus Finl (NASDAQ: ALRS) is gearing up to share its quarterly earnings report on a forthcoming Monday. Investors are on the edge of their seats, eagerly anticipating insights into the company’s performance and forecasts for the upcoming quarter. Analysts predict that Alerus Finl will achieve an earnings per...

Continue Reading
DXC Technology Unveils London Center to Enhance AI Solutions

Updated Category News Views 133

DXC Technology Unveils New Customer Experience Center in London DXC Technology (NYSE: DXC), a prominent enterprise technology partner, has recently inaugurated its Customer Experience Center in London. This center is set to transform how businesses harness artificial intelligence (AI) by assisting them in moving from merely experimenting with AI technologies to achieving...

Continue Reading
Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT

Updated Category News Views 188

Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT Coave Therapeutics, a leader in genetic medicine innovation, recently presented compelling data regarding its advanced suprachoroidal capsid, coAAV-SCS-01, at the European Society of Gene and Cell Therapy Congress 2025 held in Seville. This innovative capsid has shown to outperform traditional capsids,...

Continue Reading
HealthPRO Canada Celebrates Work Culture Achievement Again

Updated Category News Views 215

HealthPRO Canada's Continued Commitment to Excellence HealthPRO Canada, a prominent provider of group contracting for healthcare, proudly announces its status as a Great Place to Work® for the fourth consecutive year. This recognition highlights the organization’s dedication to fostering a supportive and inclusive work environment. Understanding the Great Place to...

Continue Reading